MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine. - Wikidata - awgldk - TriplyDB

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.

http://www.wikidata.org/entity/Q35987380

about

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma.MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20.Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks.Expression of Pim-3 in colorectal cancer and its relationship with prognosis.Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway.miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer.Chemoresistance in pancreatic cancer: Emerging concepts Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.

P2860

Q28080153-955FD7ED-ADC1-4AC8-9DF3-F5E5A3B56705 Q37022196-933D8FF7-B243-4206-BB65-5B97750E92A5 Q37233255-5102C8B0-606C-4E6F-8087-04865D2D14EE Q37520584-8F2372B6-5A0B-4EFC-A6DB-12CCACA2E08F Q37619788-E482FE7C-2543-4280-8522-303203E6E6FD Q38701714-91EF7111-CC33-4A4B-913A-275A6C391C4C Q38804384-7B91819E-16BC-44C0-AC18-BA9E3F2248DA Q38960311-7DB94AFD-3A0E-486D-8E1F-681C6C1F5CE2 Q40107005-80C61EBE-DF09-4155-8269-6D328EB421D5 Q41180138-C6FE918A-C432-4682-AA58-E1323952CF50 Q41694147-C57D2CE9-58B8-4405-83AA-8B04D46CD07B Q42002078-909BBFFF-C32B-4C79-9162-7B32401F3E6C Q42700754-6535C293-85C4-42AD-94EC-66D8D51E7B4C Q47107545-6C2E472D-324F-47FF-AE86-FF1C35559AC0 Q47352692-8EA69EBA-AF71-4D21-98B7-DAC00AD7E59B Q50252299-986F3710-821C-48FD-97A2-B3CA59CDFDE6 Q52646480-84E80511-3FEB-4C82-8674-1DE4DA0002C7 Q55383330-276747A1-203C-4ADC-B621-33AB93948C4B

P2860

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.

http://www.wikidata.org/entity/Q35987380

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

MicroRNA-33a-mediated downregu ...... ls sensitivity to gemcitabine.

@ast

MicroRNA-33a-mediated downregu ...... ls sensitivity to gemcitabine.

@en

type

label

MicroRNA-33a-mediated downregu ...... ls sensitivity to gemcitabine.

@ast

MicroRNA-33a-mediated downregu ...... ls sensitivity to gemcitabine.

@en

prefLabel

MicroRNA-33a-mediated downregu ...... ls sensitivity to gemcitabine.

@ast

MicroRNA-33a-mediated downregu ...... ls sensitivity to gemcitabine.

@en

P1433

Q35987380-43B032B8-F1AE-42C4-AA58-F9A1938F8A37

P1476

Q35987380-21C0206A-6302-4635-923D-6B1A0ED8EB7E

P2093

Q35987380-1A322679-6354-4F91-8085-F7D5CF9B48D9

Q35987380-2639F1B4-1CB3-4AF9-BC66-5E9C2B386BA9

Q35987380-60289A5F-A060-4066-A142-96AE4BC5B837

Q35987380-6082710D-5E37-4196-8059-2FFFFBF7D030

Q35987380-74B8C753-A7AB-461B-8C95-F37529019DE2

Q35987380-7FE46D21-6ADA-4E35-93E0-DC91A40D8BED

Q35987380-CF6E0817-4FB2-43D0-BA38-DFA0E0F6A459

Q35987380-FBD96DD6-C64F-4398-A36E-BB3B2BC564F7

P2860

Q35987380-16A8DD61-330F-42F3-B484-3859EE8A1F0E

Q35987380-19FFD83A-9A5A-4E94-9373-1EEE5ED7E71B

Q35987380-1A79E2D6-2A37-4BC2-A7C2-CC2985EA5162

Q35987380-1BA82A0A-40D9-4E2A-9298-7BBD549061AE

Q35987380-224B67B3-A5EF-4D61-A226-BDB48DD896E9

Q35987380-25DF41C8-4396-405A-A0E3-003A59DBAAFD

Q35987380-27F20FF5-8689-4F89-885B-58CB3192513E

Q35987380-28FA86F7-5B0F-4A50-81E1-CAD7C75C9932

Q35987380-3578ED3A-5546-4B5B-A210-C6AD87394CE9

Q35987380-380B9484-C0EE-4857-828B-0F1EB79503EC

P304

Q35987380-A25C4F45-A448-47B8-BFB9-9B83F4B4F027

P31

Q35987380-B24B47FB-2B38-4C4F-A2E0-CD3B5AD32DFF

P356

Q35987380-37724A31-1D13-466E-BEDA-F78DA4C93085

P407

Q35987380-9D0F82C1-D271-412A-9A10-ED8F21C45700

P433

Q35987380-07CBFFAB-1F75-4C96-B770-BA610E314465

P478

Q35987380-16C457F2-7036-4161-A0A5-B80D13BF8999

P50

Q35987380-4540C9CE-5319-4F47-A212-6583882B6E5C

Q35987380-C8F6FF4A-5263-40FE-A574-2D9DF180E635

P577

Q35987380-3BB07935-45F5-4112-AFF7-A6D83E719440

P5875

Q35987380-BE738AE3-DECF-4A11-B2C0-6EFE9D8D4C20

P698

Q35987380-30100C11-03F7-406B-83AF-5DC1B31F65D2

P921

Q35987380-11E6E881-E717-4781-B53F-741D155E84A1

P932

Q35987380-307BEE20-5D52-4C33-B75F-45E2A2E0BA26

P356

ONCOTARGET.3885

P1433

P1476

MicroRNA-33a-mediated downregu ...... lls sensitivity to gemcitabine

@en

P2093

Hong-Yu Li

http://www.w3.org/2001/XMLSchema#string

Meng-Hong Sun

http://www.w3.org/2001/XMLSchema#string

Quan-Xing Ni

http://www.w3.org/2001/XMLSchema#string

Xian-Jun Yu

http://www.w3.org/2001/XMLSchema#string

Xiao-Zhong Guo

http://www.w3.org/2001/XMLSchema#string

Yao Song

http://www.w3.org/2001/XMLSchema#string

Ying-Yi Li

http://www.w3.org/2001/XMLSchema#string

Zhen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis

Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors

Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

Cancer statistics, 2015

Oncomirs - microRNAs with a role in cancer

MicroRNA signatures in human cancers

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

P304

14440-14455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3885

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Naofumi Mukaida

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276360922

http://www.w3.org/2001/XMLSchema#string

P698

25971209

http://www.w3.org/2001/XMLSchema#string

P921

P932

4546478

http://www.w3.org/2001/XMLSchema#string